| Bioactivity | 8-Br-7-CH-cADPR (7-Deaza-8-bromo-cADPR) is a potent cADPR antagonist. 8-Br-7-CH-cADPR shows partial inhibition of calcium elevation caused by sTIR dimerization. 8-Br-7-CH-cADPR significantly decreases Paclitaxel (HY-B0015)-induced axon degeneration[1]. |
| CAS | 189876-06-0 |
| Formula | C16H21BrN4O13P2 |
| Molar Mass | 619.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yihang Li, et al. Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN. J Cell Biol. 2022 Feb 7;221(2):e202106080. |
8-Br-7-CH-cADPR
CAS: 189876-06-0 F: C16H21BrN4O13P2 W: 619.21
8-Br-7-CH-cADPR (7-Deaza-8-bromo-cADPR) is a potent cADPR antagonist. 8-Br-7-CH-cADPR shows partial inhibition of calciu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.